Center of attention has moved to the newest working thing: management's energy is disproportionately on a small but alre
The model's full reasoning — Q3 2018 call → NOWe need to determine if management devotes a disproportionate share of energy, enthusiasm, and detail to one identifiable part of the business that is still a minority of overall results today, and that part is described as already producing real, current business (actual revenue, orders, customers, volumes, etc.), with management treating it as the main driver. Let's analyze the transcript. The call covers several aspects: Liquid Biopsy (ICP), Pathology Services, and new technologies (IV-Cell, HemeScreen). The CEO starts with ICP, describing product development, panels, and the Perkin Elmer partnership. He says "we estimate 2019 revenues between several hundreds to several million dollars resulting from the market penetration of ICP" - that's future revenue, not current. He also mentions "we're working on several go-to-market strategies" - future. So ICP is described as having potential, but not yet producing significant current revenue. The Perkin Elmer agreement is a co-marketing agreement, not yet generating revenue. So ICP is not described as already producing real, current business. Pathology services: The CEO says "our revenues from pathology services growing close to 50% from the previous quarter" and "we expect a continued rapid growth" and "revenues from pathology services alone exceeding $1 million per quarter by the middle of 2019." So pathology services are currently generating revenue and growing. But is it the favored piece? The CEO spends time on it, but also on ICP and new technologies. He says "the pathology services side of the business serves not only as a positive revenue generator for the company; it also serves as the marketing and testing platform for new technologies." So pathology is a base, but the new technologies are the future. New technologies: IV-Cell and HemeScreen. IV-Cell is described as being commercialized, but no current revenue mentioned. HemeScreen: "Since the launch of the test in our lab, only two weeks ago, we've already received numerous orders -- we've already run numerous orders received from physicians." That is current activity. He says "we believe that given the market volume and revenue numbers of the current inferior test, that HemeScreen can generate revenues in excess of $1 million in 2019" - that's future. But he does mention current orders.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| LTRX | Lantronix, Inc. | Q3 2024 | 2024-04-29 | C |
| HUYA | HUYA Inc. | Q4 2023 | 2024-03-19 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| PUMP | ProPetro Holding Corp. | Q4 2023 | 2024-02-21 | C+ |
| APAM | Artisan Partners Asset Management Inc. | Q3 2023 | 2023-11-01 | C+ |
| ANGO | AngioDynamics, Inc. | Q1 2024 | 2023-10-04 | B |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| CALX | Calix, Inc. | Q1 2023 | 2023-04-20 | C+ |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| BLZE | Backblaze, Inc. | Q3 2022 | 2022-11-11 | D |
| PKX | POSCO Holdings Inc. | Q3 2022 | 2022-10-24 | D |
| YMM | Full Truck Alliance Co. Ltd. | Q2 2022 | 2022-08-25 | C+ |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| ZENV | Zenvia Inc. | Q4 2021 | 2022-03-17 | C+ |
| KD | Kyndryl Holdings, Inc. | Q4 2021 | 2022-03-01 | C+ |
| SLQT | SelectQuote, Inc. | Q2 2022 | 2022-02-07 | F |
| ZH | Zhihu Inc. | Q3 2021 | 2021-11-22 | D |
| CYBR | CyberArk Software Ltd. | Q3 2021 | 2021-11-04 | B+ |
| LPTH | LightPath Technologies, Inc. | Q4 2021 | 2021-09-09 | D |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| UFI | Unifi, Inc. | Q4 2021 | 2021-08-07 | B |
| ADSK | Autodesk, Inc. | Q3 2019 | 2018-11-20 | A |
| LRN | Stride, Inc. | Q1 2019 | 2018-10-23 | B |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| MKC | McCormick & Company, Incorporated | Q2 2018 | 2018-06-28 | C+ |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| INST | Instructure's | Q4 2017 | 2018-02-12 | B+ |
| HOLX | Hologic, Inc. | Q4 2017 | 2017-11-08 | D |
| MITK | Mitek Systems, Inc. | Q4 2017 | 2017-11-07 | C+ |
| GNTX | Gentex Corporation | Q3 2017 | 2017-10-20 | B |
| PTC | PTC Inc. | Q3 2017 | 2017-07-19 | C+ |
| NWSA | News Corporation | Q2 2016 | 2016-08-08 | C+ |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| WK | Workiva Inc. | Q4 2015 | 2016-03-01 | B |
YMM · Q2 2022 → YESThe question is: Does management devote a clearly DISPROPORTIONATE share of its energy, enthusiasm, and detail to ONE identifiable part of the business that is still a MINORITY of the company's overal...YES The transcript shows management devoting a clear, extended spotlight to the commission/online transaction service (20%+ of revenue, minority share). They repeatedly highlight its strong performance, dynamic adjustments, user retention metrics, and role in driving monetization and future growth, framing it as a key driver for the company's trajectory while 347.8 million in commissions is already generating real revenue now. Other areas like overall GTV, fulfillment rates, and user MAUs receive routine coverage, but the commission piece gets the richest, most conviction-driven discussion.
PUMP · Q4 2023 → YESThe question is: Does management devote a clearly DISPROPORTIONATE share of its energy, enthusiasm, and detail to ONE identifiable part of the business that is still a MINORITY of the company's overal...YES The transcript shows management devoting a clearly disproportionate share of its prepared remarks and Q&A to the FORCE electric fleet offering (a new technology/service line). They describe it as minority today (only two fleets operating out of 14-15 active, with plans for three and four more), yet repeatedly highlight its real 2023 performance (on contract, strong results, efficient performance, customer satisfaction, diesel displacement), its unique positioning, and its role as the core driver of the company's future trajectory through fleet transition and industrialization.
NICE · Q4 2023 → YESThe question is: Does management devote a clearly DISPROPORTIONATE share of its energy, enthusiasm, and detail to ONE identifiable part of the business that is still a MINORITY of the company's overal...YES The transcript shows management devoting a clearly disproportionate share of its energy, enthusiasm, and detail to AI (Enlighten AI, Copilot, Autopilot) as the catalyst driving growth across CXone, digital engagement, platformization, and new solutions. This is framed as the overarching theme that will shape the 2024 trajectory and beyond. AI is described as already producing real, current business activity: 375% increase in Enlighten bookings in Q4, multiple seven-digit ACV deals won with AI features, and accelerating adoption among customers and prospects.